A Pharmacokinetic Study Comparing SCT400 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma

NCT02456207 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

B-cell Non Hodgkin's Lymphoma

Interventions

DRUG: SCT400
DRUG: Rituximab

Sponsor

Sinocelltech Ltd.